Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
Healthy participants:
- Men and women between 21 and 80 years of age
- People with a body mass index (BMI) between 18.5 and 30 (a measure of body weight relative to height)
Participants with Alzheimer's disease:
- People who have test results confirming the presence of Alzheimer's-related proteins in the brain (detected through brain scans, spinal fluid, or blood tests)
- People who have mild memory or thinking difficulties, or mild-to-moderate dementia
- People with a BMI between 18.5 and 30
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who cannot have an MRI scan, such as those with claustrophobia (fear of enclosed spaces), metal implants, or a pacemaker
- Women who are pregnant or breastfeeding
- People with a neurological condition affecting the brain or nervous system (this applies to healthy participants only)
- People with a mental illness
- People with significant heart or blood vessel disease affecting the brain or body
- People who have recently taken part in a procedure involving radioactive substances
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Keith St Lawrence, PhD, Lawson Research Institute
Phone: (519) 646-6100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cerebral Metabolic Rate of Oxygen (CMRO2); Cerebral Metabolic Rate of Glucose (CMRGlu)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.